MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41392-021-00634-z

Медицинская библиотека · Signal transduction and targeted therapy · 2021

A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity.

Yang Ren, Deng Yao, Huang Baoying, Huang Lei, Lin Ang, Li Yuhua, Wang Wenling, Liu Jingjing, Lu Shuaiyao, Zhan Zhenzhen, Wang Yufei, A Ruhan, Wang Wen, Niu Peihua, Zhao Li, Li Shiqiang, Ma Xiaopin, Zhang Luyao, Zhang Yujian, Yao Weiguo, Liang Xingjie, Zhao Jincun, Liu Zhongmin, Peng Xiaozhong, Li Hangwen, Tan Wenjie

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Although inoculation of COVID-19 vaccines has rolled out globally, there is still a critical need for safe and effective vaccines to ensure fair and equitable supply for all countries. Here, we report on the development of a highly efficacious mRNA vaccine, SW0123 that is composed of sequence-modified mRNA encoding the full-length SARS-CoV-2 Spike protein packaged in core-shell structured lipopolyplex (LPP) nanoparticles. SW0123 is easy to produce using a large-scale microfluidics-based apparatus. The unique core-shell structured nanoparticle facilitates vaccine uptake and demonstrates a high colloidal stability, and a desirable biodistribution pattern with low liver targeting effect upon intramuscular administration. Extensive evaluations in mice and nonhuman primates revealed strong immunogenicity of SW0123, represented by induction of Th1-polarized T cell responses and high levels of antibodies that were capable of neutralizing not only the wild-type SARS-CoV-2, but also a panel of variants including D614G and N501Y variants. In addition, SW0123 conferred effective protection in both mice and non-human primates upon SARS-CoV-2 challenge. Taken together, SW0123 is a promising vaccine candidate that holds prospects for further evaluation in humans.

Для цитирования: Yang Ren, Deng Yao, Huang Baoying, Huang Lei, Lin Ang, Li Yuhua, Wang Wenling, Liu Jingjing, Lu Shuaiyao, Zhan Zhenzhen, Wang Yufei, A Ruhan, Wang Wen, Niu Peihua, Zhao Li, Li Shiqiang, Ma Xiaopin, Zhang Luyao, Zhang Yujian, Yao Weiguo, Liang Xingjie, Zhao Jincun, Liu Zhongmin, Peng Xiaozhong, Li Hangwen, Tan Wenjie. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity.. Signal transduction and targeted therapy. 2021. DOI: 10.1038/s41392-021-00634-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.